bibliographicCitation |
Haghnejad V, Le Berre C, Dominique Y, Zallot C, Guillemin F, Peyrin-Biroulet L. Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease. Dig Liver Dis. 2020 Mar;52(3):281–8. doi: 10.1016/j.dld.2019.09.012. PMID: 31648920. |